Mass Medical Angels
Ketan Kapadia is a seasoned professional with extensive experience in life sciences strategy and consulting. Currently serving as a Partner at ClearView Healthcare Partners since March 2018, Ketan focuses on corporate, therapeutic, and product-level strategies within a top-rated consulting firm. Ketan is also a board advisor at Symbiotix Health, which leverages blockchain technology for patient benefit, and a member of Mass Medical Angels. Previously, Ketan held significant roles at PwC Strategy& and Monitor Deloitte, leading initiatives in pharmaceutical and life sciences sectors, while also contributing to early-stage venture development at Solidea Capital and guiding client engagements at Acquis Consulting Group. Ketan began a consulting career at PwC, focusing on life sciences transformation internationally. Ketan holds a Bachelor of Science degree in Mechanical Engineering from Lehigh University.
This person is not in any teams
Mass Medical Angels
Mass Medical Angels (MA2) was founded to answer the need for a dedicated life-science centric angel group in New England. The Boston area is a world-leading supercluster for medical innovation, but all early-stage companies in the field have tremendous difficulty with first round funding. Our goal is to provide money and mentoring to the life science community to achieve superior returns for our group, and more clinical innovation for the community. Our focus is on early stage life science companies looking to raise $250K to $3.0M. Depending on the amount of funding needed, we can fund all or a portion of the round, and will work closely with other angel groups or venture funds in the area to complete the round. We are looking for companies that are extremely capital efficient opportunities where our funds will lead to significant step-ups in valuation to avoid unfavorable future funding rounds.